Crosstree Capital Partners represented and advised Medical Device Consultants, Inc. (MDCI) in it's sale to Aptiv Solutions.
Please direct inquiries to:
Shane C. Senior, CFA
Crosstree Capital Partners, Inc.
Medical Device Consultants Inc. (MDCI) had a 30 year history of success in supporting medical device development to both, emerging and established companies. Crosstree Capital Partners was brought in to assist with finding a strategic partner to acquire and support MDCI.
Crosstree approached Aptiv Solutions as it was looking for a strategic partners to expand it's regulatory capabilities within the US. Both companies were leading providers of clinical trial management services to the medical device industry but MDCI provided more emphasis on regulatory and clinical trial requirements, and Aptiv had a larger focus on trial management.
The result was a transaction that provided Aptiv Solutions with expanded regulatory services providing more services and becoming a "one stop shop" to it's clients.
Medical Device Consultants, Inc. (MDCI) offers regulatory, quality assurance, compliance, and clinical trial management services to the medical device and diagnostic industries. MDCI is a recognized leader in addressing regulatory and clinical trial requirements for emerging growth firms and well-established medical device and diagnostic innovators. The company has developed, prepared and submitted more than 600 successful 510(k)s, participated in the development of over 20 successful PMAs, and managed hundreds of clinical trials to support medical device approvals and clearance in the US, Europe, and around the globe.
Aptiv Solutions is a full-service international CRO with proven expertise in supporting global clinical trials for biopharmaceutical and medical device companies. Aptiv Solution's well-designed trials span the development lifecycle from first-in-human through regulatory approval and beyond.
"Reston, Virginia, August 22, 2011 – Aptiv Solutions announced today the acquisition of Medical Device Consultants, Inc. (MDCI), a provider of expert medical device consulting and clinical trial management and execution. Aptiv Solutions is one of the leading providers of clinical trial management services to the medical device industry. This acquisition adds new complementary regulatory and quality assurance capabilities to our portfolio of offerings as well as strengthening our existing clinical trial management services.
Founded in 1980, MDCI has offered regulatory, quality assurance, compliance, and clinical trial management services to the medical device and diagnostic industries. MDCI is a recognized leader in addressing regulatory and clinical trial requirements for emerging growth firms and well-established medical device and diagnostic innovators. The company has developed, prepared and submitted more than 600 successful 510(k)s, participated in the development of over 20 successful PMAs, and managed hundreds of clinical trials to support medical device approvals and clearance in the US, Europe, and around the globe. This acquisition brings a strong team of dedicated professionals adding depth and breadth to the Aptiv Solutions medical device consulting and clinical trial services business. Aptiv Solutions has offered clinical trial management services to the medical device industry since 1983, helping clients earn 32 PMA and HDE approvals through innovative designs accompanied by full-service clinical trial support and site management.
The increased rigor demanded by regulatory agencies around the world for medical device development and approvals requires the expertise and scale of a global service provider with focus on the unique aspects of medical devices. With the addition of MDCI’s deep knowledge base, Aptiv Solutions will provide an enhanced range of strategic consulting and medical device trial experience to current and prospective clients.
With the transaction complete, Aptiv Solutions Chairman and CEO Patrick Donnelly said: “We are excited to announce the acquisition of MDCI, one of the premier medical device consulting firms. We look forward to leveraging the unique expertise of MDCI’s thirty-year success, with our existing portfolio of device and diagnostic consulting offerings, across a broad array of therapeutic areas. We are delighted to welcome the seasoned group of medical device and diagnostic experts from MDCI to the company, as we continue to broaden our acumen in medical device and adaptive trial methodology.”
Bill Morton, President and Founder of MDCI, added, “We are thrilled to join Aptiv Solutions. This transaction is the result of an extensive and detailed search by both parties to identify the optimal partner. I am confident that by joining MDCI’s core medical device expertise with the leadership position of Aptiv Solutions, clients of both firms will receive expert, comprehensive and integrated regulatory affairs and clinical trial support for innovative medical device and diagnostics products now and in the future.”
MDCI was represented by Crosstree Capital Partners in this transaction.
Crosstree Capital Partners is a specialty advisory firm with a dedicated focus on select subsectors of the life sciences and healthcare industries, including drug and device outsourcing, diagnostic products and services, life sciences tools, medical technology, and healthcare information technology. Within these subsectors, Crosstree assists clients with corporate finance activities, including mergers and acquisitions advisory and growth capital financings. Crosstree's deep sector coverage offers clients unique industry insights, well-established strategic relationships across the globe and superior access to the capital markets. While Crosstree draws distinct industry lines of coverage, the firm has no geographic boundaries. Crosstree has advised clients throughout North America, Europe, India, China, Latin America and Australia. Crosstree Capital Partners, Inc. is an affiliate of Crosstree Capital Securities, LLC, which is a member of FINRA and SIPC. Crosstree’s website is http://www.crosstreecapital.com.
Crosstree Capital Partners is a micro-industry focused investment bank, providing strategic advisory services, including mergers and acquisitions, recapitalizations, and growth capital placements, to leading clients within its focused industries.
Crosstree is the leading source of related valuation and transactional data for its focus industries. Publications are available exclusively to website subscribers on dedicated industry portals. To access Crosstree’s proprietary industry portals and related publications and data, please login or click here to join.
Copyright © 2012 • Crosstree Capital Partners • All rights reserved•